Changes in expression of cytokines in polyhexamethylene guanidine-induced lung fibrosis in mice: Comparison of bleomycin-induced lung fibrosis

Toxicology

Volumn 393, Issue , 2018, Pages 185-192

  Kim, Min Seok ^a   Kim, Sung Hwan ^a,b   Jeon, Doin ^a   Kim, Hyeon Young ^a   Lee, Kyuhong ^a,b  

^a Korea Institute of Toxicology   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

Bleomycin; Cytokine; Polyhexamethylene guanidine; Pulmonary fibrosis

Indexed keywords

ADIPONECTIN; B CELL ACTIVATING FACTOR; BLEOMYCIN; CXCL16 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; CYTOKINE ANTIBODY; DELTA LIKE 1 HOMOLOG PROTEIN; EOTAXIN; GELATINASE A; GROWTH ARREST SPECIFIC PROTEIN 6; GUANIDINE DERIVATIVE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12P40; INTERLEUKIN 1ALPHA; INTERLEUKIN 33; KIDNEY INJURY MOLECULE 1; LEPTIN; LIF PROTEIN; MYELOPEROXIDASE; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR BB; POLYHEXAMETHYLENE GUANIDINE; SERPINE1 PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG; WISP1 PROTEIN; POLYHEXAMETHYLENEGUANIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; BODY WEIGHT; BRONCHIOLE; CELL COUNT; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; EOSINOPHIL COUNT; EPITHELIUM HYPERPLASIA; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG FIBROSIS; LUNG LAVAGE; LUNG WEIGHT; LYMPHOCYTE COUNT; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; ORGAN WEIGHT; POLYHEXAMETHYLENE GUANIDINE INDUCED LUNG FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; UPREGULATION; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; LUNG; MACROPHAGE; NEUTROPHIL; PATHOLOGY;

ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYTOKINES; GUANIDINES; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PULMONARY FIBROSIS;

EID: 85034852980     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2017.11.017     Document Type: Article

References (46)

1. Arai, T., et al. Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 278 (2000), L914–L922.
2. Arizmendi, N., et al. Rac2 is involved in bleomycin-induced lung inflammation leading to pulmonary fibrosis. Respir. Res., 2014, 10.1186/1465-9921-15-71.
3. Azuma, A., et al. Interferon-beta inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-beta and thrombospondin. Am. J. Respir. Cell. Mol. Biol. 32 (2005), 93–98.
4. Bethany, B., Cory, M., Murine models of pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 294 (2008), L152–L160.
5. Borthwick, L.A., et al. Cytokine mediated tissue fibrosis. Biochim. Biophys. Acta 1832 (2013), 1049–1060.
6. Fan, X., Wang, Z., STAT1 antisense oligonucleotides attenuate the proinflammatory cytokine release of alveolar macrophages in bleomycin-induced fibrosis. Cell. Mol. Immunol. 2 (2005), 211–217.
7. Hong, S.B., Kim, H.J. Huh, Do, J.W., Jang, K.H., Song, S.J., Choi, J.S., Heo, S.J., Kim, Y., Lim, Y.B., Chae, C.M., Lee, E.J., Jung, H., Lee, M., Lee, K., Koh, M.S., Korean Unknown Severe Respiratory Failure Collaborative, Korean Study Group of Respiratory Failure A cluster of lung injury associated with home humidifier use: clinical, radiological and pathological description of a new syndrome. Thorax 69 (2014), 694–702.
8. Huang, C.C., et al. The human delta-like 1 homologue is implicated in the progression of liver fibrosis in biliary atresia. J. Pathol. 202 (2004), 172–179.
9. Huang, L.S., et al. Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. FASEB. J. 27 (2013), 1749–1760.
10. Huaux, F., et al. Am. J. Respir. Cell. Mol. Biol. 18:1 (1998), 51–59.
11. Khalil, N., et al. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170 (1989), 727–737.
12. Izbicki, G., Segel, M.J., Christensen, T.G., Conner, M.W., Breuer, R., Time course of bleomycin-induced lung fibrosis. Int. J. Exp. Pathol. 83 (2002), 111–119.
13. Janick-Buckner, D., Ranges, G.E., Hacker, M.P., Alteration of bronchoalveolar lavage cell populations following bleomycin treatment in mice. Toxicol Appl Pharmacol. 100 (1989), 465–473.
14. Kim, J.Y., et al. Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis. Yonsei Med. J. 50 (2009), 68–77.
15. Kim, K.W., et al. Humidifier disinfectant-associated children's interstitial lung disease. Am. J. Respir. Crit. Care. Med. 189 (2014), 48–56.
16. Kim, H.J., et al. A cluster of lung injury cases associated with home humidifier use an epidemiological investigation. Thorax 69 (2014), 703–708.
17. Kim, H.R., et al. The role of NF-kB signaling pathway in polyhexamethylene guanidine phosphate induced inflammatory response in mouse macrophage RAW264.7 cells. Toxicol. Lett. 233 (2015), 148–155.
18. Kim, H.R., et al. Adverse health effects of humidifier disinfectants in Korea: lung toxicity of polyhexamethylene guanidine phosphate. J. Toxicol. Sci. 41 (2016), 711–717.
19. Kim, H.R., et al. Polyhexamethylene guanidine phosphate aerosol particles induce pulmonary inflammatory and fibrotic responses. Arch. Toxicol., 90, 2016, 617632.
20. Kim, M.S., et al. Analysis of genomic responses in a rat lung model treated with a humidifier sterilizer containing polyhexamethyleneguanidine phosphate. Toxicol. Lett. 268 (2017), 36–43.
21. Korea Centers for Disease Control and Prevention, In-depth investigation on the cases of lung injury with unknown cause. Public. Health. Wkly. Rep. 4 (2011), 829–832.
22. Leivo-Korpela, S., et al. Adipokine adipsin is associated with the degree of lung fibrosis in asbestos-exposed workers. Respir. Med. 106 (2012), 1435–1440.
23. Li, M.O., et al. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24 (2006), 99–146.
24. Lippmann, M., Deposition and retention of inhaled fibres: effects on incidence of lung cancer and mesothelioma. Occup. Environ. Med. 51 (1994), 793–798.
25. Lung Injury Investigation Committee, White Paper on the Health Damage Disaster from Humidifier Disinfectants. 2014, Korea Ministry of Health and Welfar, Sejong, 12–99.
26. Moldoveanu, B., Otmishi, P., Jani, P., Walker, J., Sarmiento, X., Guardiola, J., Saad, M., Yu, J., Inflammatory mechanisms in the lung. J. Inflamm Res. 2 (2009), 1–11.
27. Moore, B.B., Hogaboam, C.M., Murine models of pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 294 (2008), L152–L160.
28. Nakagome, K., et al. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung. Thorax 61 (2006), 886–894.
29. Park, S., et al. Humidifier disinfectant-associated interstitial lung disease in an animal model induced by polyhexamethylene guanidine aerosol. Am. J. Respir. Crit. Care Med. 190 (2014), 706–708.
30. Park, D.U., et al. Relationship between exposure to household humidifier disinfectants and risk of lung injury: a family-based study. PLoS One, 10, 2015, e0124610.
31. Park, K.S., An analysis of a humidifier disinfectant case from a toxicological perspective. Environ. Health Toxicol., 31, 2016, e2016013.
32. Parsons, C.J., et al. Molecular mechanisms of hepatic fibrogenesis. J. Gastroenterol. Hepatol. 22 (2007), S79–S84.
33. Pechkovsky, D.V., et al. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin. Immunol. 137 (2010), 89–101.
34. Randell, S.H., Airway epithelial stem cells and the pathophysiology of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 3 (2006), 718–725.
35. Romero, F., et al. A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis. Am. J. Respir. Cell. Mol. Biol. 53 (2015), 74–86.
36. Rosin, M., et al. Effect of a polyhexamethylene biguanide mouthrinse on bacterial counts and plaque. J. Clin. Periodontol. 28 (2001), 1121–1126.
37. Sainaghi, P.P., et al. Gas6 evaluation in patients with acute dyspnea due to suspected pulmonary embolism. Respir. Med. 103 (2009), 589–594.
38. Sauni, R., et al. Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers. Occup. Environ. Med. 69 (2012), 256–260.
39. Shibata, T., et al. Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma. J. Immunol. 192 (2014), 3569–3581.
40. Smith, R.E., et al. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J. Leukoc. Biol. 64 (1998), 528–536.
41. Song, J.A., et al. Polyhexamethyleneguanidine phosphate induces severe lung inflammation, fibrosis, and thymic atrophy. Food Chem. Toxicol. 69 (2014), 267–275.
42. Taylor, M.L., et al. Extensive surface phenotyping of alveolar macrophages in interstitial lung disease. Clin. Immunol. 94 (2000), 33–41.
43. Traustadottir, G.A., et al. Preadipocytes proliferate and differentiate under the guidance of Delta-like 1 homolog (DLK1). Adipocyte 2 (2013), 272–275.
44. Wynn, T.A., Cellular and molecular mechanisms of fibrosis. J. Pathol. 214 (2008), 199–210.
45. Zhang-Hoover, J., et al. A critical role for alveolar macrophages in elicitation of pulmonary immune fibrosis. Immunology 101 (2000), 501–511.
46. Zhu, N.L., et al. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration. J. Biol. Chem. 287 (2012), 10355–10367.